AHA Scientific Sessions 2026 Abstract

Blocking a collagen-linking enzyme improved heart failure in rats

Male rats with heart failure had heart relaxation times of 25.24 milliseconds with the inhibitor, compared with 27.20 milliseconds without it.

Heart cross-sections show sparse linked fibers in dark blue-green tissue and dense fibers in gray tissue, beside a laboratory rat and two aortic arches.

Our read

Mechanisms
Studied:
Experiments in obese ZSF1 rats with induced heart failure, against male rats without the inhibitor
What changed:
Heart relaxation time was lower in treated male rats: 25.24 milliseconds against 27.20 milliseconds without the inhibitor
The catch:
The untreated male heart-relaxation comparison reports only n=7

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

Obese ZSF1 rats given Sugen were used in an animal experiment on heart failure with preserved ejection fraction, in which the heart retains its pumping ability. The researchers tested PAT1251, which inhibits LOXL2, an enzyme that links fibers of the structural protein collagen.

Male rats developed pronounced heart dysfunction, while females before menopause were protected. After ovary removal, females developed a more pronounced disease pattern, though it was less severe than in males. The authors reported that PAT1251 reversed the heart failure pattern in both sexes, with benefits particularly in males. It also reduced the increased stiffness of the aorta, the body’s main artery. The drug did not change body weight, heart rate or blood pressure.

Why it matters

Heart failure with preserved ejection fraction disproportionately affects women after menopause. The findings support further investigation of LOXL2 as a target for the structural heart changes involved in this disease.

Caveats

The results came from an experimentally induced rat model, with ovary removal used to represent menopause. The conference abstract does not give the drug’s dose or treatment duration.

Comments

Be the first to comment.